You are here: Industry Insights > CRT

News List

EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients pharmatimes
August 03, 2021
Bristol Myers Squibb (BMS) has announced that the European Commission (EC) has approved Opdivo (nivolumab) for the adjuvant treatment of adult patients with oesophageal or gastroesophageal junction (GEJ) cancer who have residual pathologic disease ...
4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research T prnasia
March 08, 2018
4C Medical Technologies, Inc. today announced that AltaValve™, its medical device for MR, was awarded first place in the Cardiovascular Research Technologies competition held March 3-6, 2018 in Washington, DC.
CRT and Merck extend partnership to discover new cancer drugs pharmaceutical-technology
July 03, 2017
UK-based Cancer Research Technology (CRT) has extended its collaboration with US pharmaceutical company Merck to discover new cancer drugs targeting the Hippo pathway.
Cancer Research UK, CRT and HitGen to develop new drugs against lung cancer pharmaceutical-technology
March 02, 2017
Cancer Research UK, Cancer Research Technology (CRT) and biotech company HitGen have signed a licence agreement to develop new drugs against lung cancer.
HITGEN and Cancer Research UK’s Manchester institute enter license agreement in lung cancer HITGEN
February 28, 2017
Cancer Research UK, Cancer Research Technology (CRT) announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.